Starpharma Holdings Ltd (OTCQX International:SPHRY)

8.79
Delayed Data
As of Apr 19
 0.00 / 0.00%
Today’s Change
4.94
Today|||52-Week Range
13.40
-16.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues250.6K669.6K2.8M2.3M
 
 
 
 
 
Depreciation And Amortization1.0M1.0M677.5K239.8K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses17.4M19.1M21.7M16.4M
 
 
 
 
 
Research And Development14.0M16.4M18.7M12.4M
 
 
 
 
 
Total Operating Expenses18.5M20.1M22.4M16.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.2M-19.4M-19.6M-14.4M
 
 
 
 
 
Interest Expense On Debt6.4K4.2K1.5K754.15
 
 
 
 
 
Other Expenses6.4K3.3K88.8K-11.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.3M-18.7M-19.1M-13.9M
 
 
 
 
 
Income Taxes-3.9M-2.9M-2.6M-2.5M
 
 
 
 
 
Discontinued Operations0.000.000.00-941.2K
 
 
Extraordinary Items0.000.000.0018.6M
 
 
Net Income-13.4M-15.8M-16.5M-12.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.4M31.0M34.5M36.8M
 
 
 
 
 
Shares To Calculate EPS Diluted28.4M31.0M34.5M36.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.46-$0.50-$0.51-$0.34
 
 
 
 
 
EPS Diluted-$0.46-$0.50-$0.51-$0.34